No Data
No Data
All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
Alliance Global Partners Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6
Vivos Therapeutics Analyst Ratings
A. G. P. Maintains Vivos Therapeutics(VVOS.US) With Buy Rating, Cuts Target Price to $6